Context Therapeutics shares #ASCO23 data on CLDN-6 targeted treatments and CTIM-76 update

By Proactive Investors / June 13, 2023 / www.youtube.com / Article Link

Context Therapeutics CEO Marty Lehr joins Natalie Stoberman from the Proactive studios to discuss the latest data on clinical ...

Recent News

Metals far outpacing tech over past year

February 09, 2026 / www.canadianminingreport.com

Gold stocks gain on metal recovery

February 09, 2026 / www.canadianminingreport.com

Immediate trigger for crash was new Fed Chairman pick

February 02, 2026 / www.canadianminingreport.com

Gold stocks slump on metal price decline

February 02, 2026 / www.canadianminingreport.com

Is the gold market starting to turn 'irrationally exuberant'?

January 26, 2026 / www.canadianminingreport.com

See all >